Contact: Edyta Zielinska
Thomas Jefferson University
Caption: Genomic tests that determine the molecular subtype of a woman's breast cancer provide a more precise prognosis and valuable guidance on treatment options, according to recent research presented this year at the San Antonio Breast Cancer Symposium (SABCS).
Credit: Thomas Jefferson University
Usage Restrictions: None
Related news release: Breast cancer treatment selection is improved by genomic tests at Jefferson Breast Care Center